← Back to Search

Orthokeratology

Orthokeratology for Near-sightedness (ALWAOM Trial)

N/A
Waitlist Available
Research Sponsored by Art Optical Contact Lens, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two years
Awards & highlights

Summary

Purpose: To determine axial length progression and its relationship with myopia onset and progression in adults.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two years
This trial's timeline: 3 weeks for screening, Varies for treatment, and two years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Axial Length progression
Effect of Orthokeratology on axial length changes

Trial Design

1Treatment groups
Experimental Treatment
Group I: OrthokeratologyExperimental Treatment1 Intervention
Orthokeratology is fitting of a contact lens for overnight wear to flatten the cornea and correct myopia temporarily during the day. This procedure has also been shown to slow down the axial length growth in children.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Orthokeratology
2016
Completed Phase 4
~290

Find a Location

Who is running the clinical trial?

Art Optical Contact Lens, Inc.Lead Sponsor
University of Missouri, St. LouisOTHER
14 Previous Clinical Trials
2,559 Total Patients Enrolled
~35 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top